Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program

Journal of Acquired Immune Deficiency Syndromes

Volumn 39, Issue 4, 2005, Pages 471-477

  Pouget, Enrique R ^a   Deren, Sherry ^a   Fuller, Crystal M ^b,c   Blaney, Shannon ^c   McMahon, James M ^a   Kang, Sung Yeon ^a   Tortu, Stephanie ^d   Andia, Jonny F ^a   Des Jarlais, Don C ^a,e   Vlahov, David ^c  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b Columbia University ^*  (United States)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

^d TULANE UNIVERSITY   (United States)

^e BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Injection drug use; Needle sharing; Pharmacy; Syringe access

Indexed keywords

ADULT; ARTICLE; ETHNIC GROUP; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; SYRINGE; UNITED STATES;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; NEW YORK CITY; ODDS RATIO; REGRESSION ANALYSIS; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 22344445603     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000152395.82885.c0     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. HIV AIDS Surveill Rep: Cases of HIV infection and AIDS in the United States. 2002;14:1-40.
2. Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis. 1997;1:559-568.
3. Centers for Disease Control and Prevention, Health Resources and Services Administration, National Institute on Drug Abuse, and Substance Abuse and Mental Health Services Administration. HIV Prevention Bulletin: Medical Advice for Persons Who Inject Illicit Drugs. Atlanta, GA; Rockville, MD; 1997.
4. Centers for Disease Control and Prevention. IDU HIV prevention fact sheet series: access to sterile syringes. Atlanta: Centers for Disease Control and Prevention; 2002. Available at: http://www.cdc.gov/idu/facts/ aed_idu_acc.htm. Accessed November 8, 2004.
5. Normand J, Vlahov D, Moses LE. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press/National Research Council/Institute of Medicine; 1995.
6. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987-991.
7. Heimer R, Khoshnood K, Bigg D, et al. Syringe use and reuse: effects of syringe exchange programs in four cities. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):S37-S44.
8. MacDonald M, Law M, Kaldor J, et al. Effectiveness of needle and syringe programmes for preventing HIV transmission. Int J Drug Policy. 2003; 14:353-357.
9. Riley ED, Safaeian M, Strathdee SA, et al. Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J Acquir Immune Defic Syndr. 2000;24:57-61.
10. Burris S, Strathdee SA, Vernick JS. Syringe access law in the United States. A state of the art assessment of law and policy as of November 30, 2002 [Johns Hopkins and Georgetown Universities, Center for Law and the Public's Health website]. Available at: http://www.publichealthlaw. net/Research/PDF/ syringe.pdf. Accessed November 8, 2004.
11. Burris S, Vernick JS, Ditzler A, et al. The legality of selling or giving syringes to injection drug users. J Am Pharm Assoc. 2002;42(Suppl 2): S13-S18.
12. Groseclose SL, Weinstein B, Jones TS, et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:82-89.
13. Cotton-Oldenburg NU, Carr P, DeBoer JM, et al. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. J Acquir Immune Defic Syndr. 2001;27:183-192.
14. Des Jarlais DC, Marmor M, Friedman P, et al. HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health. 2000;90:352-359.
15. Des Jarlais DC, Perils T, Friedman SR, et al. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health. 2000;90:1112-1116.
16. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002;186:1558-1564.
17. Klein SJ, Birkhead GS. Candelas AR. Expanded syringe access demonstration program in New York State: an intervention to prevent HIV/AIDS transmission. J Urban Health. 2000;77:762-767.
18. New York State Department of Health. Expanded Syringe Access Demonstration Program (ESAP): overview of the law and regulations, 2001. Available at: http://www.health.state.ny.us/nysdoh/hivaids/esap/regover.htm. Accessed November 8, 2004.
19. New York State Department of Health. Part 80-rules and regulations on controlled substances [statutory authority: Public Health Law Article 33, §3381(6)(e)], 2001. Available at: http://www.health.state.ny.us/nysdoh/ hivaids/esap/fullregs.htm. Accessed November 8, 2004.
20. Des Jarlais DC, McKnight C, Friedmann P Legal syringe purchases by injection drug users in Brooklyn and Queens, 2000-2001. J Am Pharm Assoc. 2002;42(Suppl 2):S73-S76.
21. Deren S, Fuller C, Pouget ER, et al. Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. Int J Drug Policy. 2003;14:373-379.
22. Finkelstein R, Tiger R, Greenwald R, et al. Pharmacy syringe sales practices during the first year of expanded syringe availability in New York City 2000-2001. J Am Pharm Assoc. 2002;42(Suppl 2):S83-S87.
23. Fuller CM, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings of injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc. 2002;42(Suppl 2): S77-S82.
24. Deren S, Oliver-Velez D, Finlinson A, et al. Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Subst Use Misuse. 2003;38:1-24.
25. Tortu S, McMahon JM, Pouget ER. et al. "She said, he said": drug-using women's perceived versus actual HIV risk from primary male partners. Presented at: Annual Meeting of the American Public Health Association; 2003; San Francisco.
26. McMahon JM, Tortu S, Torres L, et al. Recruitment of heterosexual couples in public health research: a study protocol. BMC Med Res Methodol [serial online], 2003;3:24. Available at: http://www.biomedcentral. com/1471-2288/3/24. Accessed November 8, 2004.
27. Agresti A. Categorical Data Analysis. 2nd ed. New York: John Wiley and Sons; 2002:181-182.
28. Preisser JS, Koch GG. Categorical data analysis in public health. Annu Rev Public Health. 1997;18:51-82.
29. Margolin BH. Test for trend in proportions. In: Klotz S, Johnson NL, eds. Encyclopedia of Statistical Sciences, vol. 9. New York: John Wiley & Sons; 1988:334-336.
30. Spittal PM, Craib KJP, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Can Med Assoc J. 2002;166:894-899.
31. Spitzer E. The New York City Police Department's "Stop & Frisk" practices: a report to the people of the State of New York from the Office of the Attorney General. New York, NY: Attorney General of the State of New York, Civil Rights Bureau; December 1, 1999. Available at: http://www. oag.state.ny.us/press/reports/stop_frisk/stop_frisk.ritml. Accessed November 8, 2004.
32. Weiser B. Judge backs drug users in needle-exchange plans. New York Times. November 21, 2002:B4.
33. Coffin PO, Linas BP, Factor SH, et al. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access. J Urban Health. 2000;77:781-793.
34. Coffin PO, Ahern J, Dorris S, et al. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. J Am Pharm Assoc. 2002;42(Suppl 2):S62-S67.
35. Tortu S, McMahon J, Hamid R. et al. Drug using women's sexual risk: an event analysis. AIDS Behav. 2000;4:329-340.